Experience of Using Genetically Engineered Insulin Preparations Produced by Farmak Company in Patients with Diabetes Mellitus Type 2

Abstract

The article deals with one of the most urgent and important socio-economic problems of clinical endocrinology — diabetes mellitus (DM). With the progression of DM, it is harder to control the disease; in this regard, insulin provides additional benefits. The findings of the study on the long-term efficacy and tolerability of all types of Farmasulin preparations in patients with diabetes mellitus type 2 are provided.

Authors and Affiliations

V. L. Orlenko, A. S. Yefimov, K. Yu. Ivaskiva

Keywords

Related Articles

Diabetes Mellitus Type 2 in the Practice of Family Physician

Over the past 10 years, the number of new cases of diabetes mellitus (DM) type 2 significantly exceeded the forecasts of experts. Uncompensated DM is a constant threat. But the results of clinical studies show that compl...

Features of Neuroendocrine and Hormonal Disorders at Growth Hormone Deficiency in Adults with Mass Lesions of Hypothalamus-Pituitary Region

In this article the author analyzes the status of 40 adults with tumors of the pituitary region, of whom 35 (87.5 %) had growth hormone deficiency with neuroendocrine complications. Specific for growth hormone deficiency...

Calcitonin, Osteocalcin and Osteopontin in Lung Cancer

Background. Lung cancer markers are low levels of the hormone calcitonin in the blood, and high levels of proteins osteocalcin and osteopontin, connected to each other, reflect the processes of bone metastasis and have a...

The biological role of iodine and iodine deficiency as pathogenetic factor of thyroid pathology in pregnant women and its prevention

The article presents the most important information about the role of iodine in biological nature, its participation in different biological processes, formation of thyroid hormones and their effects on different organs...

Hypothyroidism and Nonthyroidal Somatic Diseases in Adolescents

The structure and correlation of thyroid dysfunction and non-thyroid pathology in adolescents was analyzed. An adequate replacement therapy of hypothyroidism, which aims to compensate its manifestations, will not only im...

Download PDF file
  • EP ID EP228627
  • DOI -
  • Views 46
  • Downloads 0

How To Cite

V. L. Orlenko, A. S. Yefimov, K. Yu. Ivaskiva (2014). Experience of Using Genetically Engineered Insulin Preparations Produced by Farmak Company in Patients with Diabetes Mellitus Type 2. Міжнародний ендокринологічний журнал, 5(61), 69-74. https://europub.co.uk./articles/-A-228627